Skip to content

Promotion of Ambulation Before Non-cardiac Surgery

Impact of a Routine of Pre-surgical Walk for Non Cardiac Adult Patients Compared to Conventional Intervention (Not Recommended Exercise) in Reducing the Length of Hospital Stay and the Time of Onset of Ambulation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03213496
Acronym
PAMP-Phase2
Enrollment
368
Registered
2017-07-11
Start date
2016-05-01
Completion date
2017-12-31
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-cardiac Surgery

Keywords

clinical trial, non cardiac surgery, walking.

Brief summary

Primary Determine the impact of prescribing a routine pre-surgical walk scheduled compared to conventional intervention (not recommended exercise) in reducing the length of hospital stay and the time of onset of ambulation during postoperative hospitalization, in patients with ability to move, ≥30 years who will undergo non-cardiac surgery. Secondary 1. Evaluate ischemic cardiovascular events (AMI), stroke (CVA) and cardiac mortality during hospitalization. 2. Evaluate the incidence of falls during hospitalization. Methodology The PAMP project phase II, as a component of CARDIECOL program will be implemented by designing a pilot study, a randomized controlled trial. Adult-patients with greater than or equal to 30 years old entering elective non-cardiac surgery, prior informed consent will be randomized to an intervention prescribed of walking in the period of 2-3 weeks before surgery or will be assigned to a Control group/conventional care. The study was not blinded to patients, but evaluation and analysis of the data will be blinded for researchers and statisticians. Patients will be evaluated on their previous level of physical activity and will be evaluated by a physiatrist doctor for prescribing the walk (exercise). This study will include a sample of 500 patients, with capacity to mobilize, ability to walk at least 30 min/by day (150 min by week) for at least 1 week before surgery. Patients have to be hospitalized for at least 24 hours after the surgical procedure. Outcomes are length of stay, and time to first walk. Other results are evaluation falls during hospitalization and the presence of falls, report of cardiovascular events, and death by group. Expected results

Detailed description

Randomization was planned to be performed one to five weeks before non-cardiac surgery for all eligible patients, once they have decided to participate in the study. It was performed on a random computed to an intervention group (Walk prescription); or conventional care group (no exercise) in a 2:1 relation respectively. Intervention and Management Processes The pre surgical intervention walk routine is defined of at least 150-300 minutes of walk before going into surgery. Analysis will be following the principle of intention to treat. A description of categorical and quantitative demographic data will be performed. Evaluation will also include the mean difference in the length of hospital stay for each of the groups and standard deviation, given a confidence interval of 95%. An analysis of the time of occurrence of the first walk using the Kaplan-Meier estimator will be performed.

Interventions

BEHAVIORALWalk prescription

30-40 minutes daily, for five days at the week, all weeks up to surgery.

OTHERConventional care

Patient do not walk before surgery

Sponsors

Fundación Cardioinfantil Instituto de Cardiología
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Data of outcomes will be evaluated by statisticians.

Intervention model description

Adult patients programmed for elective non-cardiac surgery, prior informed consent, will be randomized to an intervention (prescription of a programed walking) in the period of 2-3 weeks before surgery or will be assigned to a control group/conventional care.

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* undergoing non-cardiac surgery * general anesthesia or epidural or spinal anesthesia * age ≥ 30 years * able to walk and communicate

Exclusion criteria

* having any alteration of their state of consciousness * altered mental status and communication

Design outcomes

Primary

MeasureTime frameDescription
Length of stayUp 40 weeks in hospitalizationTotal stay hours

Secondary

MeasureTime frameDescription
FallsUp 40 weeks in hospitalizationFall event reported in patients´ charts
Ischemic eventsUp 40 weeks in hospitalizationMyocardial infarction or stroke
Time to the first walkUp 40 weeks in hospitalizationFirst time out of the bed registered in patients´charts

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026